Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non-Small-Cell Lung Cancer According to ALK Fusion and Mutation Status
Related Posts
Tamada Y, Walling AM, Wray CM, Reuben DB, Wenger NS, Damberg CL, Zingmond DS, Xu H, Gotanda H, Tsugawa Y. Comparison of end-of-life care processes[...]
Hijazi W, Mostafavi S, Shanbhag A, Ramirez G, Lemley M, Miller RJH, Kavanagh PB, Liang JX, Kamagate A, Alexanderson E, Carvajal-Juarez I, Slipczuk L, Travin[...]
LIFT-HCC Investigators; Rezaee-Zavareh MS, Wang T, Tabrizian P, Yeo YH, Ji F, Adetyan H, Luu M, Zhong S, Marino R, Ward SC, Abdelrahim M, Esmail[...]